J Immunol.
2016 Jun 15;196(12):5101-11. doi: 10.4049/jimmunol.1600212. Epub 2016 May 4.
LSm14A Plays a Critical Role in Antiviral Immune Responses by Regulating MITA Level in a Cell-Specific Manner.
- 1College of Life Sciences, Medical Research Institute, Collaborative Innovation Center for Viral Immunology, State Key Laboratory of Virology, Wuhan University, Wuhan 430072, China; and.
- 2Wuhan Institute of Virology, State Key Laboratory of Virology, Chinese Academy of Sciences, Wuhan 430071, China.
- 3College of Life Sciences, Medical Research Institute, Collaborative Innovation Center for Viral Immunology, State Key Laboratory of Virology, Wuhan University, Wuhan 430072, China; and shuh@whu.edu.cn.
Abstract
Viral infection triggers induction of antiviral cytokines and effectors, which are critical mediators of innate antiviral immune response. It has been shown that the processing body-associated protein LSm14A is involved in the induction of antiviral cytokines in cell lines but in vivo evidence is lacking. By generating LSm14A-deficient mice, in this study, we show that LSm14A plays a critical and specific role in the induction of antiviral cytokines in dendritic cells (DCs) but not in macrophages and fibroblasts. Induction of antiviral cytokines triggered by the DNA viruses HSV-1 and murid herpesvirus 68 and the RNA virus vesicular stomatitis virus but not Sendai virus was impaired in Lsm14a(-/-) DCs, which is correlated to the functions of the adaptor protein MITA/STING in the antiviral signaling pathways. LSm14A deficiency specifically downregulated MITA/STING level in DCs by impairing its nuclear mRNA precursor processing and subsequently impaired antiviral innate and adaptive immune responses. Our findings reveal a nuclear mRNA precursor processing and cell-specific regulatory mechanism of antiviral immune responses.
Copyright © 2016 by The American Association of Immunologists, Inc.
上一条:The Type I Interferon-IRF7 Axis Mediates Transcriptional Expression of Usp25 Gene.
下一条:The VP3 structural protein of foot-and-mouth disease virus inhibits the IFN-β signaling pathway.